Protein / target
Small ribosomal subunit protein uS19
Protein at a glance
Biological role
Structural constituent of ribosome
Derived from structured UniProt, Open Targets and literature data on this page.
Protein profile
Canonical identity and biological annotation from UniProt.
Function
In the E.coli 70S ribosome in the initiation state (PubMed:12809609) it has been modeled to contact the 23S rRNA of the 50S subunit forming part of bridge B1a; this bridge is broken in the model with bound EF-G. The 23S rRNA contact site in bridge B1a is modeled to differ in different ribosomal states (PubMed:12859903), contacting alternately S13 or S19. In the 3.5 angstroms resolved ribosome structures (PubMed:16272117) the contacts between L5, S13 and S19 bridge B1b are different, confirming the dynamic nature of this interaction. Bridge B1a is not visible in the crystallized ribosomes due to 23S rRNA disorder
Domains and Gene Ontology detail (7)Hide
Gene Ontology
- Ccytoplasm
- Ccytosol
- Ccytosolic small ribosomal subunit
- FrRNA binding
- Fstructural constituent of ribosome
- FtRNA binding
- Pcytoplasmic translation
Drugs targeting this protein
Whether each drug engages this protein directly or through a complex, and how many other targets are recorded for it. Direct binders with few recorded targets are listed first.
Bacterial 70S ribosome inhibitor
Bacterial 70S ribosome inhibitor
Bacterial 70S ribosome inhibitor
Bacterial 70S ribosome inhibitor
Bacterial 70S ribosome inhibitor
Bacterial 70S ribosome inhibitor
Bacterial 70S ribosome inhibitor
Bacterial 70S ribosome inhibitor
ChEMBL mechanism, action type and target identity. Open Targets clinical status and indications.
Clinical trials
Trials of drugs that target this protein — reached indirectly through those drugs, so a trial listed here studies the drug, not the protein.
Show remaining trials (24)Hide
ClinicalTrials.gov via the drug-target graph.
What's happening now
Recent activity around this target, drawn from one canonical event stream. Every item is reached through 8 drugs that target this protein, so each event is news about that drug rather than about the protein directly.
- Industry developmentFe-doped BiVO4/g-C3N4 heterojunction for efficient tetracycline degradation under low-intensity UV irradiation
- Label change
Label change: DOXYCYCLINE (ANDA204234)
- Label change
Label change: DOXYCYCLINE (ANDA204234)
- Label change
Label change: DOXYCYCLINE (ANDA204234)
- Label change
Label change: DOXYCYCLINE (ANDA207757)
- New publicationImpact of pneumococcal conjugate vaccines on invasive pneumococcal disease-causing lineages among South African children.
- New publicationGuidelines of care for the management of acne vulgaris.
- New publicationNew Antibiotics for Multidrug-Resistant Bacterial Strains: Latest Research Developments and Future Perspectives.
- Safety communication
Drug Safety Update: Erythromycin: update on known risk of infantile hypertrophic pyloric stenosis
- Safety communication
Drug Safety Update: Erythromycin: caution required due to cardiac risks (QT interval prolongation); drug interaction with rivaroxaban
- New publicationRisk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19).
- Label change
Label change: DOXYCYCLINE (ANDA207757)
Objective event titles are shown unmodified; the event kind and significance line are derived from structured fields. Forefront AttentionEvent stream aggregating Europe PMC Regulatory filings ClinicalTrials.gov.